Allakos Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALLK Nasdaq 2834 http://www.allakos.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Allakos Inc

Why Allakos Stock Was Heating Up Today - Mar 7th, 2023 9:05 pm
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results - Mar 6th, 2023 9:02 pm
Is Allakos Inc. (NASDAQ:ALLK) Expensive For A Reason? A Look At Its Intrinsic Value - Jan 26th, 2023 10:33 am
Is Allakos (NASDAQ:ALLK) In A Good Position To Deliver On Growth Plans? - Dec 15th, 2022 4:35 pm
Allakos Inc. (ALLK) Moves to Buy: Rationale Behind the Upgrade - Dec 9th, 2022 5:00 pm
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology - Nov 29th, 2022 12:02 pm
Allakos Presents Preclinical Data on AK007, a Siglec-10 Antagonist Antibody, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting - Nov 10th, 2022 2:02 pm
Allakos Provides Business Update and Reports Third Quarter 2022 Financial Results - Nov 7th, 2022 9:05 pm
3 Healthcare Stocks to Sell Before They Die - Sep 30th, 2022 3:48 pm
After losing 95% in the past year, Allakos Inc. (NASDAQ:ALLK) institutional owners must be relieved by the recent gain - Sep 24th, 2022 12:32 pm
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock - Sep 19th, 2022 11:00 am
Allakos Announces Initiation of Phase 2b Clinical Trial of Subcutaneous Lirentelimab in Chronic Spontaneous Urticaria (CSU) - Sep 12th, 2022 11:02 am
After Disappointing Data, Allakos Discontinues Work On Lirentelimab In Eosinophilic Gastrointestinal Diseases - Sep 9th, 2022 12:47 pm
Allakos Announces Topline Phase 3 Data from the EoDyssey Study in Patients with Eosinophilic Duodenitis - Sep 9th, 2022 11:00 am
Why Allakos Stock Is on Fire Today - Aug 31st, 2022 6:10 pm
Allakos Provides Business Update and Reports Second Quarter 2022 Financial Results - Aug 4th, 2022 8:04 pm
Allakos Announces the Appointment of Dr. Amy Ladd to its Board of Directors - Jul 25th, 2022 8:05 pm
Companies Like Allakos (NASDAQ:ALLK) Could Be Quite Risky - Jul 8th, 2022 2:18 pm
Allakos Provides Business Update and Reports First Quarter 2022 Financial Results - May 6th, 2022 8:05 pm
Allakos Inc. (ALLK) Stock Sinks As Market Gains: What You Should Know - Apr 28th, 2022 10:00 pm